Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Biochem Pharmacol. 2017 Sep 21;145:18–26. doi: 10.1016/j.bcp.2017.09.006

Figure 1.

Figure 1

Naïve T-cells can be used as cell carriers due to their organotropism. a) Naïve T-cells circulate throughout the body and are able to home to lymph nodes. b) Bioluminescence imaging of mice treated after 16 days. Naïve T-cells loaded with SN-38 lipid nanocapsules reduced tumor burden. c) Overall survival of mice treated with PBS, SN-38, SN-38 NC, and SN-38 NC conjugated to T-cells.